HomeCompareMPLN vs ARCC

MPLN vs ARCC: Dividend Comparison 2026

MPLN yields 8.64% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MPLN wins by $10.9K in total portfolio value
10 years
MPLN
MPLN
● Live price
8.64%
Share price
$23.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.4K
Annual income
$1,490.69
Full MPLN calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — MPLN vs ARCC

📍 MPLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMPLNARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MPLN + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MPLN pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MPLN
Annual income on $10K today (after 15% tax)
$734.34/yr
After 10yr DRIP, annual income (after tax)
$1,267.09/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, MPLN beats the other by $1,266.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MPLN + ARCC for your $10,000?

MPLN: 50%ARCC: 50%
100% ARCC50/50100% MPLN
Portfolio after 10yr
$30.0K
Annual income
$745.91/yr
Blended yield
2.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

MPLN
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Price Target
$10.00
-56.8% upside vs current
Range: $10.00 — $10.00
Altman Z
-0.4
Piotroski
5/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MPLN buys
0
ARCC buys
0
No recent congressional trades found for MPLN or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMPLNARCC
Forward yield8.64%10.65%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$35.4K$24.5K
Annual income after 10y$1,490.69$1.14
Total dividends collected$11.8K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$10.00$21.88

Year-by-year: MPLN vs ARCC ($10,000, DRIP)

YearMPLN PortfolioMPLN Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$11,564$863.93$11,373$532.74+$191.00MPLN
2$13,307$933.69$12,608$279.46+$699.00MPLN
3$15,243$1,004.14$13,809$142.90+$1.4KMPLN
4$17,385$1,074.96$15,042$72.20+$2.3KMPLN
5$19,747$1,145.80$16,341$36.27+$3.4KMPLN
6$22,346$1,216.38$17,732$18.18+$4.6KMPLN
7$25,197$1,286.41$19,231$9.10+$6.0KMPLN
8$28,316$1,355.62$20,851$4.55+$7.5KMPLN
9$31,722$1,423.78$22,605$2.28+$9.1KMPLN
10$35,433$1,490.69$24,504$1.14+$10.9KMPLN

MPLN vs ARCC: Complete Analysis 2026

MPLNStock

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Full MPLN Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this MPLN vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MPLN vs SCHDMPLN vs JEPIMPLN vs OMPLN vs KOMPLN vs MAINMPLN vs HTGCMPLN vs GBDCMPLN vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.